MedPath

SINAI HOSPITAL OF BALTIMORE

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

3 Phases

Phase 2:1
Phase 4:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (33.3%)
Phase 2
1 (33.3%)
Phase 4
1 (33.3%)

Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and Controls

Not Applicable
Conditions
Neoplasm
Interventions
First Posted Date
2015-05-21
Last Posted Date
2015-05-21
Lead Sponsor
Sinai Hospital of Baltimore
Target Recruit Count
50
Registration Number
NCT02450175
Locations
🇺🇸

SInai Hospital of Baltimore, Inc., Baltimore, Maryland, United States

Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer

Phase 2
Conditions
Ovarian Cancer
Endometrial Cancer
Interventions
First Posted Date
2014-07-11
Last Posted Date
2015-05-19
Lead Sponsor
Sinai Hospital of Baltimore
Target Recruit Count
20
Registration Number
NCT02188550
Locations
🇺🇸

Sinai Hospital of Baltimore, Inc., Baltimore, Maryland, United States

A Comparison of Subvastus and Midvastus Approaches in Minimally-Invasive Total Knee Arthroplasty

Phase 4
Completed
Conditions
Total Knee Arthroplasty
First Posted Date
2009-02-20
Last Posted Date
2009-02-20
Lead Sponsor
Sinai Hospital of Baltimore
Target Recruit Count
51
Registration Number
NCT00848133
Locations
🇺🇸

Bonutti Clinic, Effingham, Illinois, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.